Pharmacy worker behaviour1 · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
2944 participants
Moderate
Pharmacy user health‐related behaviour3 (Higher scores indicate a better outcome) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
2138 participants
Moderate
Pharmacy user intermediate clinical outcomes e.g. cholesterol, glycated haemoglobin5 (Lower scores indicate a better outcome) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
3971 participants
Moderate
Pharmacy user event‐based clinical outcomes e.g. stroke, myocardial infarction · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
Pharmacy user quality of life6 (Higher scores indicate better quality of life) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
2687 participants
Moderate
Adverse events · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
Costs · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Functional ability · cancer patients
1 finding from 1 review
Physical status Multiple scales. Scale from: 0 to 100. · cancer patients
1 finding from 1 review
Psychological status Multiple scales. Scale from: 0 to 100. · cancer patients
1 finding from 1 review
Social needs Multiple scales. Scale from: 0 to 100. · cancer patients
1 finding from 1 review
Satisfaction Multiple scales. Scale from: 0 to 100. · cancer patients
1 finding from 1 review
QoL · cancer patients
1 finding from 1 review
Perinatal mortality rate (overall) (at month 12–26) · births
Perinatal death review and audit as part of an intervention package… showed no clear difference in perinatal mortality rate (overall) (at month 12–26) compared with no intervention (low certainty).
1 finding from 1 review
Proportion of perinatal deaths related to suboptimal carec (at months 12–26) · births
It is very uncertain whether perinatal death review and audit as part of an intervention package… changes proportion of perinatal deaths related to suboptimal carec (at… compared with no intervention (very low certainty).
1 finding from 1 review
Mortality measured by mortality rates including failure‐to‐rescuerates (3a) Stillbirth · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal mortality · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality rate in children < 5 years of age · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal mortality ‐ not reported · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of perinatal morbidity cases related to suboptimal carec (at months 12–26) · births
Perinatal death review and audit as part of an intervention package… probably leads to lower proportion of perinatal morbidity cases related to suboptimal carec… compared with no intervention (moderate certainty).
1 finding from 1 review